Virtual event

Virtual event: Democrats’ last chance for drug pricing reform?

Editor’s note: A recording of the event is embedded below.

OOnce again, Congress is moving toward drug pricing reform. STAT will meet with key decision makers to discuss the latest developments from Capitol Hill and the White House.

Agenda:

advertising

Introduction:

  • Brent DoverCEO, Kalderos (sponsor speaker)

Part 1: Listen to the Experts

advertising

  • Rena Conti, Ph.D.Associate Professor, Department of Markets, Public Policy and Law, Questrom School of Business, Boston University
  • Stacie B. Dusetzina, Ph.D.Associate Professor of Health Policy, Ingram Associate Professor of Cancer Research, Vanderbilt University School of Medicine
  • Richard G. Frank, Ph.D., director of the USC-Brookings Schaeffer Initiative on Health Policy; scholarship holder in economic studies; Margaret T. Morris Professor of Health Economics, Emeritus, Department of Health Care Policy, Harvard Medical School
  • Rachel Cohrscorrespondent in Washington, STAT (moderator)

Part 2: The perspective of a great senator

  • Senator Ron Wyden (Golden.)Chairman of the Senate Finance Committee
  • Rachel Cohrscorrespondent in Washington, STAT (moderator)